GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmala Biotech Holdings Inc (OTCPK:MDXXF) » Definitions » YoY Rev. per Sh. Growth

MDXXF (Pharmala Biotech Holdings) YoY Rev. per Sh. Growth : 0.00% (As of Feb. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Pharmala Biotech Holdings YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Pharmala Biotech Holdings's YoY Rev. per Sh. Growth for the quarter that ended in Feb. 2024 was 0.00%.

Pharmala Biotech Holdings's Revenue per Share for the three months ended in Feb. 2024 was $0.00.

Pharmala Biotech Holdings YoY Rev. per Sh. Growth Historical Data

The historical data trend for Pharmala Biotech Holdings's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmala Biotech Holdings YoY Rev. per Sh. Growth Chart

Pharmala Biotech Holdings Annual Data
Trend Aug21 Aug22 Aug23
YoY Rev. per Sh. Growth
- - 400.00

Pharmala Biotech Holdings Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
YoY Rev. per Sh. Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -100.00 - - -

Pharmala Biotech Holdings YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Pharmala Biotech Holdings's YoY Rev. per Sh. Growth for the fiscal year that ended in Aug. 2023 is calculated as:

YoY Rev. per Sh. Growth (A: Aug. 2023 )
=(Revenue per Share (A: Aug. 2023 )-Revenue per Share (A: Aug. 2022 ))/ | Revenue per Share (A: Aug. 2022 ) |
=(0.005-0.001)/ | 0.001 |
=400.00 %

Pharmala Biotech Holdings's YoY Rev. per Sh. Growth for the quarter that ended in Feb. 2024 is calculated as:

YoY Rev. per Sh. Growth (Q: Feb. 2024 )
=(Revenue per Share (Q: Feb. 2024 )-Revenue per Share (Q: Feb. 2023 )) / | Revenue per Share (Q: Feb. 2023 )) |
=(0.001-0.001)/ | 0.001 |
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmala Biotech Holdings YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Pharmala Biotech Holdings's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmala Biotech Holdings Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmala Biotech Holdings Inc (OTCPK:MDXXF) » Definitions » YoY Rev. per Sh. Growth
Comparable Companies
XCNQ:ASEP XCNQ:PHRM XCNQ:COOL TSXV:QPT XCNQ:TELI TSX:AEZS XCNQ:BLAB NEOE:BMND TSXV:NRX TSXV:KNE OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
MDMA:Canada
Address
82 Richmond Street East, Toranto, ON, CAN, M5C 1P1
Website
https://www.pharmala.ca
Pharmala Biotech Holdings Inc is focused on manufacturing and sales of MDMA and MDXX Active Pharmaceutical Ingredients (API) for use in clinical research. PharmAla's drug API is manufactured and encapsulated under GMP conditions. The Company generates revenue from the sale of tablets and raw MDMA and MDXX compounds/formulations.